ADORE · FAB 122-CT-2001
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A multicenter, randomized, double-blind, placebo-controlled study investigating the efficacy and safety of FAB122 in patients with amyotrophic lateral sclerosis. EudraCT: 2020-003376-40.
Sponsor: Ferrer Internacional
Phase: III
Area: Neuromuscular disorders